Evidence map›Paper›PMID 32590732›Full record

SynthesisMedicine2020

Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis.

Anna Biasioli, Ambrogio P Londero, Maria Orsaria, Federica Scrimin, Francesco Paolo Mangino, Serena Bertozzi, Laura Mariuzzi, Angelo Cagnacci

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Anna BiasioliClinic of Obstetrics and Gynecology, University Hospital of Udine.
Ambrogio P LonderoClinic of Obstetrics and Gynecology, University Hospital of Udine.ORCID 0000-0001-6429-1220
Maria OrsariaInstitute of Pathology, University Hospital of Udine.
Federica ScriminInstitute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste (TS).
Francesco Paolo ManginoInstitute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste (TS).
Serena BertozziEnnergi Research.
Laura MariuzziInstitute of Pathology, University Hospital of Udine.
Angelo CagnacciClinic of Obstetrics and Gynecology, DINOGMI, IRCCS San Martino Hospital, University of Genova, Genova (GE), Italy.
University of Udine · ITIRCCS Materno Infantile Burlo Garofolo · ITMartin University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtypical polypoid adenomyoma (APA) is a rare uterine tumor typically found in fertile age and associated with infertility. Among young nullipara women, conservative treatment is proposed despite the high recurrence rate and the association with endometrial cancer.Our aim was to assess the risk of recurrence with different conservative treatments in fertile ages and the prevalence of malignant or pre-malignant associated lesions to better address an adequate patient counselling when treatment modalities are discussed.

methodsThis study is a systematic review and meta-analysis of case reports and case series about APA management and follow-up. A literature search was carried from Medline and Scopus for studies published from January 1, 1980 to December 31, 2018.

resultsWe included 46 observational studies and 296 cases in fertile women. The prevalence of APA relapse was 44% (CI.95 33-57%) and was lower in cases treated with operative hysteroscopy (22%; CI.95 11-39%) than in cases treated with blind curettage and polypectomy (38%; CI.95 15-67%). The prevalence of the concomitant or during the follow-up diagnosis of endometrial carcinoma was 16% (CI.95 9-29%). The risk of cancer development during follow-up was significantly less in cases treated with histeroscopy (10.56% new cumulative diagnosis at 5 years follow up; CI.95 0-23.7%) than blind curettage and polypectomy (35.5% new cumulative diagnosis at 5 years; CI.95 11.65-52.92%; P < .05). Medical treatment with medroxyprogesterone acetate after surgery does not reduce APA recurrence. Pregnancy was observed in 79% cases in which the desire was expressed.

conclusionThis review suggests that conservative treatment performed by operative hysteroscopy is the optimal choice because it lowers the risk of recurrence, improves the accuracy of concomitant carcinoma or hyperplasia diagnosis, and leaves the possibility of future pregnancies.

Indexed as

AdenomyomaAntineoplastic Agents, HormonalChemotherapy, AdjuvantConservative TreatmentCurettageEndometrial HyperplasiaEndometrial NeoplasmsFemaleHumansHysteroscopyMedroxyprogesterone AcetateNeoplasm Recurrence, LocalNeoplasms, Multiple PrimaryPregnancyPregnancy RateUterine NeoplasmsAntineoplastic Agents, HormonalMedroxyprogesterone Acetate

Identifiers

PMID32590732
PMCPMC7328951
OpenAlexW3037361294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.